Chapter 1. Introduction


1.1. Report Description And Scope

1.2. Research Scope

1.3. Research Methodology


1.3.1. Market Research Process

1.3.2. Market Research Methodology

Chapter 2. Executive Summary


2.1. Global STD Diagnostics Market, 2015 - 2021 (USD Billion)

2.2. Global STD Diagnostics Market: Snapshot

Chapter 3. STD Diagnostics  Market Dynamics


3.1. Introduction

3.2. Value Chain Analysis

3.3. Market Drivers


3.3.1. Global STD Diagnostics Market Drivers: Impact Analysis

3.3.2. Rapid Spread Of Human Papilloma Virus (HPV) Infection

3.3.3. Having Multiple Sex Partners

3.4. Market Restraints


3.4.1. Global STD Diagnostics Market Restraints: Impact Analysis

3.4.2. Lack Of Education Regarding The Prevalence Of STD Problem

3.5. Opportunities


3.5.1. Covering Untapped Market

3.6. Porters Five Forces Analysis


3.6.1. Bargaining Power Of Suppliers

3.6.2. Bargaining Power Of Buyers

3.6.3. Threat From New Entrants

3.6.4. Threat From New Substitutes

3.6.5. Degree Of Competition

3.7. Market Attractiveness Analysis


3.7.1. Market Attractiveness Analysis, By Type Segment

3.7.2. Market Attractiveness Analysis, By End- User Segment

3.7.3. Market Attractiveness Analysis, By Testing Device Segment

3.7.4. Market Attractiveness Analysis, By Regional Segment

Chapter 4. Global STD Diagnostics Market  Competitive Landscape


4.1. Company Market Share, 2015 (Subject To Data Availability)

4.2. Strategic Development


4.2.1. Acquisitions  Mergers

4.2.2. New Type Launch

4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures

4.2.4. Research And Development, Regional Expansion

4.3. Type Portfolio

Chapter 5. Global STD Diagnostics Market  Test Analysis


5.1. Global STD Diagnostics Market: Test Overview


5.1.1. Global STD Diagnostics Market Revenue Share, By Test , 2015 And 2021

5.2. Chlamydia Testing


5.2.1. Global Chlamydia Testing Market, 2015  2021 (USD Billion)

5.3. Syphilis Testing


5.3.1 Global Syphilis Testing Market, 2015  2021 (USD Billion)

5.4. Gonorrhea Testing


5.4.1. Global Gonorrhea Testing Market, 2015  2021 (USD Billion)

5.5. Herpes Simplex Virus Testing


5.5.1. Global Herpes Simplex Virus Testing Market, 2015  2021 (USD Billion)

5.6. Human Papilloma Virus Testing


5.6.1. Global Human Papilloma Virus Testing Market, 2015  2021 (USD Billion)

5.7. Human Immunodeficiency Virus Testing


5.7.1 Global Human Immunodeficiency Virus Testing Market, 2015  2021 (USD Billion)

5.8. Others


5.8.1. Global Other STD Diagnostics Market, 2015  2021 (USD Billion)

Chapter 6. Global STD Diagnostics Market  End- Users Analysis


6.1. Global STD Diagnostics Market: End- Users Segment Overview


6.1.1. Global STD Diagnostics Market Revenue Share, By End- Users, 2015 And 2021

6.2. Hospitals


6.2.1. Global STD Diagnostics Market For Hospitals , 2015  2021 (USD Billion)

6.3. Others


6.3.1. Global STD Diagnostics For Others End- Users Market, 2015  2021 (USD Billion)

Chapter 7. Global STD Diagnostics Market  Testing Device Analysis


7.1. Global STD Diagnostics Market: Testing Device Segment Overview


7.1.1. Global STD Diagnostics Market Revenue Share, By Testing Device, 2015 And 2021

7.2. Laboratory Devices


7.2.1. Global STD Diagnostics Market For Laboratory Devices, 2015  2021 (USD Billion)

7.3. Point Of Care Device


7.3.1. Global STD Diagnostics For Point Of Care Device Market, 2015  2021 (USD Billion)

Chapter 8. Global STD Diagnostics Market  Regional Segment Analysis


8.1. Global STD Diagnostics Market: Regional Overview


8.1.1. Global STD Diagnostics Market Revenue Share, By Region, 2015 And 2021

8.2. North America


8.2.1. North America STD Diagnostics Market Revenue, By Type , 2015  2021 , (USD Billion)

8.2.2. North America STD Diagnostics Market Revenue, By End- User, 2015  2021 , (USD Billion)

8.2.3. North America STD Diagnostics Market Revenue, By Testing Device , 2015  2021 , (USD Billion)

8.2.4. U.S.


8.2.4.1. U.S. STD Diagnostics Market Revenue, By Type , 2015  2021 (USD Billion)

8.2.5. U.S.


8.2.5.1. U.S. STD Diagnostics Market Revenue, By End- Users, 2015  2021 (USD Billion)

8.2.6. U.S.


8.2.6.1. U.S. STD Diagnostics Market Revenue, By Testing Device , 2015  2021 (USD Billion)

8.3. Europe


8.3.1. Europe STD Diagnostics Market Revenue, By Type , 2015  2021 (USD Billion)

8.3.2. Europe STD Diagnostics Market Revenue, By End- Users, 2015  2021 (USD Billion)

8.3.3. Europe STD Diagnostics Market Revenue, By Testing Device , 2015  2021 (USD Billion)

8.3.4. Germany


8.3.4.1. Germany STD Diagnostics Market Revenue, By Type , 2015  2021, (USD Billion)

8.3.4.2. Germany STD Diagnostics Market Revenue, By End- Users, 2015  2021, (USD Billion)

8.3.4.3. Germany STD Diagnostics Market Revenue, By Testing Device , 2015  2021, (USD Billion)

8.3.5. France


8.3.5.1. France STD Diagnostics Market Revenue, By Type , 2015  2021, (USD Billion)

8.3.5.2. France STD Diagnostics Market Revenue, By End- Users, 2015  2021, (USD Billion)

8.3.5.3. France STD Diagnostics Market Revenue, By Testing Device , 2015  2021, (USD Billion)

8.3.6. UK


8.3.6.1. UK STD Diagnostics Market Revenue, By Type , 2015  2021 (USD Billion)

8.3.6.2. UK STD Diagnostics Market Revenue, By End- Users, 2015  2021 (USD Billion)

8.3.6.3. UK STD Diagnostics Market Revenue, By Testing Device , 2015  2021 (USD Billion)

8.4. Asia Pacific


8.4.1. Asia Pacific STD Diagnostics Market Revenue, By Type , 2015  2021 (USD Billion)

8.4.2. Asia Pacific STD Diagnostics Market Revenue, By End- Users, 2015  2021 (USD Billion)

8.4.3. Asia Pacific STD Diagnostics Market Revenue, By Testing Device , 2015  2021 (USD Billion)

8.4.4. China


8.4.4.1. China STD Diagnostics Market Revenue, By Type , 2015  2021 (USD Billion)

8.4.4.2. China STD Diagnostics Market Revenue, By End- Users, 2015  2021 (USD Billion)

8.4.4.3. China STD Diagnostics Market Revenue, By Testing Device , 2015  2021 (USD Billion)

8.4.5. Japan


8.4.5.1. Japan STD Diagnostics Market Revenue, By Type , 2015  2021 (USD Billion)

8.4.5.2. Japan STD Diagnostics Market Revenue, By End- Users, 2015  2021 (USD Billion)

8.4.5.3. Japan STD Diagnostics Market Revenue, By Testing Device , 2015  2021 (USD Billion)

8.4.6. India


8.4.6.1. India STD Diagnostics Market Revenue, By Type , 2015  2021 (USD Billion)

8.4.6.2. India STD Diagnostics Market Revenue, By End- Users, 2015  2021 (USD Billion)

8.4.6.3. India STD Diagnostics Market Revenue, By Testing Device , 2015  2021 (USD Billion)

8.5. Latin America


8.5.1. Latin America STD Diagnostics Market Revenue, By Type , 2015  2021 (USD Billion)

8.5.2. Latin America STD Diagnostics Market Revenue, By End- Users, 2015  2021 (USD Billion)

8.5.3. Latin America STD Diagnostics Market Revenue, By Testing Device , 2015  2021 (USD Billion)

8.5.4. Brazil


8.5.4.1. Brazil STD Diagnostics Market Revenue, By Type , 2015  2021 (USD Billion)

8.5.4.2. Brazil STD Diagnostics Market Revenue, By End- Users, 2015  2021 (USD Billion)

8.5.4.3. Brazil STD Diagnostics Market Revenue, By Testing Device , 2015  2021 (USD Billion)

8.6. Middle East And Africa


8.6.1. Middle East And Africa STD Diagnostics Market Revenue, By Type , 2015  2021 (USD Billion)

8.6.2. Middle East And Africa STD Diagnostics Market Revenue, By End- Users, 2015  2021 (USD Billion)

8.6.3. Middle East And Africa STD Diagnostics Market Revenue, By Testing Device , 2015  2021 (USD Billion)

Chapter 9. Company Profile


9.1. Roche Holdings AG


9.1.1. Overview

9.1.2. Financials

9.1.3. Product Portfolio

9.1.4. Business Strategy

9.1.5. Recent Developments

9.2. Abbott Laboratories


9.2.1. Overview

9.2.2. Financials

9.2.3. Product Portfolio

9.2.4. Business Strategy

9.2.5. Recent Developments

9.3. Becton Dickinson and Company


9.3.1. Overview

9.3.2. Financials

9.3.3. Product Portfolio

9.3.4. Business Strategy

9.3.5. Recent Developments

9.4. Hologic Inc.


9.4.1. Overview

9.4.2. Financials

9.4.3. Product Portfolio

9.4.4. Business Strategy

9.4.5. Recent Developments

9.5. Danaher Corporation


9.5.1. Overview

9.5.2. Financials

9.5.3. Product Portfolio

9.5.4. Business Strategy

9.5.5. Recent Developments

9.6. Affymetrix


9.6.1. Overview

9.6.2. Financials

9.6.3. Product Portfolio

9.6.4. Business Strategy

9.6.5. Recent Developments

9.7. bioMerieux


9.7.1. Overview

9.7.2. Financials

9.7.3. Product Portfolio

9.7.4. Business Strategy

9.7.5. Recent Developments

9.8. Cepheid Inc.


9.8.1. Overview

9.8.2. Financials

9.8.3. Product Portfolio

9.8.4. Business Strategy

9.8.5. Recent Developments

9.9. Alere Inc.


9.9.1. Overview

9.9.2. Financials

9.9.3. Product Portfolio

9.9.4. Business Strategy

9.9.5. Recent Developments

9.10. DiaSorin


9.10.1. Overview

9.10.2. Financials

9.10.3. Product Portfolio

9.10.4. Business Strategy

9.10.5. Recent Developments

9.11. Orasure


9.11.1. Overview

9.11.2. Financials

9.11.3. Product Portfolio

9.11.4. Business Strategy

9.11.5. Recent Developments